Psilocybin is a psychoactive alkaloid with hallucinogenic properties found in various mushrooms. It has gained interest as a tool to study psychosis and for its therapeutic benefits. This paper reviews its metabolism, mechanisms, toxicology, and pharmacology. Psilocybin shows positive effects on depression, addiction, anxiety, and obsessive-compulsive disorder, clarifying its potential for treating mental illnesses. It is described as having low toxicity and no side effects, offering new treatment ideas.
Meditation alters brain structure and brain waves, yet the precise neural mechanisms remain unclear. This review categorizes common meditation types, describes changes in the prefrontal cortex, hippocampus, and gray matter density, and summarizes psychological and clinical effects. It connects micro- and macro-level mechanisms and highlights meditation's potential in clinical treatment, but notes that neuron circuit changes require further research.
Psilocybin shows significant potential for treating mental disorders, outperforming traditional drugs, especially in cancer patients with severe conditions by reducing depression and controlling substance abuse. Healthcare professionals treating eating disorders are interested in its application. However, unresolved side effects remain. Overall, psilocybin is scientifically effective and morally accepted by clinicians, suggesting future widespread use could mark a major medical advance.